About APP Pharma
APP Pharma was founded in 2002 and is headquartered in Schaumburg, United States. Operations are conducted in the pharmaceutical sector, with a focus on the production of generic injectable drugs for healthcare providers. Leadership is provided by CEO John Ducker. The companys activities are centered in the United States, serving domestic markets through established distribution channels. Limited public details are available on specific services or expansions.
- Headquarter Schaumburg, United States
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of APP Pharma
Detailed funding history for APP Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in APP Pharma
APP Pharma has secured backing from 1 investor. Prominent investors backing the company include Fresenius.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
System-critical products and services for healthcare therapies are provided.
|
Locked | Locked | Locked |
Investor details for APP Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by APP Pharma
Investment portfolio details for APP Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - APP Pharma
Detailed financials for APP Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
App Pharma Comparisons
Peer comparison for APP Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of APP Pharma
Detailed competitors of APP Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on App Pharma
Complete news archive for APP Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about APP Pharma
APP Pharma was founded in 2002.
APP Pharma is headquartered in Schaumburg, United States. It is registered at Schaumburg, Illinois, United States.
John Ducker is the current CEO of APP Pharma.
APP Pharma was founded in 2002 and is headquartered in Schaumburg, United States. Operations are conducted in the pharmaceutical sector, with a focus on the production of generic injectable drugs for healthcare providers. Leadership is provided by CEO John Ducker. The companys activities are centered in the United States, serving domestic markets through established distribution channels. Limited public details are available on specific services or expansions.
APP Pharma has 1 investor. Key investors include Fresenius.